171 related articles for article (PubMed ID: 7028873)
1. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
[TBL] [Abstract][Full Text] [Related]
2. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
3. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
Aota F; Chang D; Hill NO; Khan A
Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
[TBL] [Abstract][Full Text] [Related]
5. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
7. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
[TBL] [Abstract][Full Text] [Related]
10. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
[TBL] [Abstract][Full Text] [Related]
11. Differentiation antigens of human hemopoietic cells: patterns of reactivity of two monoclonal antibodies.
Pessano S; Bottero L; Faust J; Trucco M; Palumbo A; Pegoraro L; Lange B; Brezin C; Borst J; Terhorst C; Rovera G
Cancer Res; 1983 Oct; 43(10):4812-5. PubMed ID: 6603905
[TBL] [Abstract][Full Text] [Related]
12. Production and analysis of HH 10 monoclonal antibodies reactive to immature hematopoietic cells and their use for monitoring acute leukemia cells.
Kato K; Naoe T; Hiraiwa A; Namikawa R; Suzuki S; Yamada K; Shiku H
Jpn J Cancer Res; 1985 Jun; 76(6):524-31. PubMed ID: 3926583
[TBL] [Abstract][Full Text] [Related]
13. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
14. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
Bernstein ID; Andrews RG; Cohen SF; McMaster BE
J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
[TBL] [Abstract][Full Text] [Related]
15. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
Hering S; Böttger V; Baryschnikow AJ; Micheel B
Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
18. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
20. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
Malcolm AJ; Shipman RC; Levy JG
J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
